162 related articles for article (PubMed ID: 15317822)
1. Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug.
Dai J; Punchihewa C; Mistry P; Ooi AT; Yang D
J Biol Chem; 2004 Oct; 279(44):46096-103. PubMed ID: 15317822
[TBL] [Abstract][Full Text] [Related]
2. Structures and dynamics of DNA complexes of the desmethyl analog of the cytotoxin MLN944: Insights into activity when a methyl isn't futile.
Serobian A; Pracey CP; Thomas DS; Denny WA; Ball GE; Wakelin LPG
J Mol Recognit; 2020 Aug; 33(8):e2843. PubMed ID: 32253794
[TBL] [Abstract][Full Text] [Related]
3. Biological characterization of MLN944: a potent DNA binding agent.
Sappal DS; McClendon AK; Fleming JA; Thoroddsen V; Connolly K; Reimer C; Blackman RK; Bulawa CE; Osheroff N; Charlton P; Rudolph-Owen LA
Mol Cancer Ther; 2004 Jan; 3(1):47-58. PubMed ID: 14749475
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the topoisomerase II poison 9-amino-[N-(2-dimethylamino)ethyl]acridine-4-carboxamide bound to the DNA hexanucleotide d(CGTACG)2.
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Biochemistry; 1999 Jul; 38(29):9221-33. PubMed ID: 10413496
[TBL] [Abstract][Full Text] [Related]
5. Novel DNA Bis-Intercalator XR5944 as a Potent Anticancer Drug-Design and Mechanism of Action.
Buric AJ; Dickerhoff J; Yang D
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299405
[TBL] [Abstract][Full Text] [Related]
6. The solution structure of bis(phenazine-1-carboxamide)-DNA complexes: MLN 944 binding corrected and extended.
Serobian A; Thomas DS; Ball GE; Denny WA; Wakelin LP
Biopolymers; 2014 Nov; 101(11):1099-113. PubMed ID: 24898663
[TBL] [Abstract][Full Text] [Related]
7. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
8. The antiproliferative agent MLN944 preferentially inhibits transcription.
Byers SA; Schafer B; Sappal DS; Brown J; Price DH
Mol Cancer Ther; 2005 Aug; 4(8):1260-7. PubMed ID: 16093442
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of a 2:1 complex of anticancer drug XR5944 with TFF1 estrogen response element: insights into DNA recognition by a bis-intercalator.
Lin C; Mathad RI; Zhang Z; Sidell N; Yang D
Nucleic Acids Res; 2014 May; 42(9):6012-24. PubMed ID: 24711371
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies of the binding of acridinecarboxamide topoisomerase poisons to DNA: implications for mode of binding of ligands with uncharged chromophores.
Wakelin LP; Adams A; Denny WA
J Med Chem; 2002 Feb; 45(4):894-901. PubMed ID: 11831901
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of the esperamicin A1-DNA complex.
Kumar RA; Ikemoto N; Patel DJ
J Mol Biol; 1997 Jan; 265(2):173-86. PubMed ID: 9020981
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the anthracycline antibiotic nogalamycin with the hexamer duplex d(5'-GACGTC)2. An NMR and molecular modelling study.
Searle MS; Bicknell W
Eur J Biochem; 1992 Apr; 205(1):45-58. PubMed ID: 1555603
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of 9-amino-N-[2-(4-morpholinyl)ethyl]-4-acridinecarboxamide bound to d(CGTACG)2: implications for structure-activity relationships of acridinecarboxamide topoisomerase poisons.
Adams A; Guss JM; Denny WA; Wakelin LP
Nucleic Acids Res; 2002 Feb; 30(3):719-25. PubMed ID: 11809884
[TBL] [Abstract][Full Text] [Related]
14. A novel form of intercalation involving four DNA duplexes in an acridine-4-carboxamide complex of d(CGTACG)(2).
Adams A; Guss JM; Collyer CA; Denny WA; Wakelin LP
Nucleic Acids Res; 2000 Nov; 28(21):4244-53. PubMed ID: 11058124
[TBL] [Abstract][Full Text] [Related]
15. On the sequence selective bis-intercalation of a homodimeric thiazole orange dye in DNA.
Bunkenborg J; Stidsen MM; Jacobsen JP
Bioconjug Chem; 1999; 10(5):824-31. PubMed ID: 10502349
[TBL] [Abstract][Full Text] [Related]
16. DNA-binding characterization of a novel anti-tumour benzo[a]phenazine derivative NC-182: spectroscopic and viscometric studies.
Tarui M; Doi M; Ishida T; Inoue M; Nakaike S; Kitamura K
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):271-9. PubMed ID: 7998945
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
Leonard DA; Rajaram N; Kerppola TK
Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
[TBL] [Abstract][Full Text] [Related]
18. Characterization of dipyridophenazine complexes of ruthenium(II): the light switch effect as a function of nucleic acid sequence and conformation.
Jenkins Y; Friedman AE; Turro NJ; Barton JK
Biochemistry; 1992 Nov; 31(44):10809-16. PubMed ID: 1420195
[TBL] [Abstract][Full Text] [Related]
19. Probing intercalation and conformational effects of the anticancer drug 2-methyl-9-hydroxyellipticinium acetate in DNA fragments with circular dichroism.
Monnot M; Mauffret O; Lescot E; Fermandjian S
Eur J Biochem; 1992 Mar; 204(3):1035-9. PubMed ID: 1551384
[TBL] [Abstract][Full Text] [Related]
20. Differential DNA recognition by the enantiomers of 1-Rh(MGP)2 phi: a combination of shape selection and direct readout.
Franklin SJ; Barton JK
Biochemistry; 1998 Nov; 37(46):16093-105. PubMed ID: 9819202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
